The pharmacokinetic and tolerability profile of once-daily Zibotentan (ZD4054) in Japanese and Caucasian patients with hormone-resistant prostate cancer.

Autoria(s): Ranson, M.; Wilson, Richard; O'Sullivan, Joe; Maruoka, M.; Yamaguchi, A.; Cowan, R.; Logue, J.; Jones, H.; Tominaga, N.; Swaisland, H.; Oliver, S.; Usami, M.
Data(s)

01/11/2010
Identificador

http://pure.qub.ac.uk/portal/en/publications/the-pharmacokinetic-and-tolerability-profile-of-oncedaily-zibotentan-zd4054-in-japanese-and-caucasian-patients-with-hormoneresistant-prostate-cancer(c940d3fa-d603-46ed-a06a-2835b8d7cee3).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Ranson , M , Wilson , R , O'Sullivan , J , Maruoka , M , Yamaguchi , A , Cowan , R , Logue , J , Jones , H , Tominaga , N , Swaisland , H , Oliver , S & Usami , M 2010 , ' The pharmacokinetic and tolerability profile of once-daily Zibotentan (ZD4054) in Japanese and Caucasian patients with hormone-resistant prostate cancer. ' International Journal of Clinical Pharmacology and Therapeutics , vol 48 (11) , pp. 708-717 .
Tipo

article
Acesso ao item digital